Related Experiment Videos
Adverse reactions to sedative/hypnotics: three years' experience
W B Mendelson1, C Thompson, T Franko
1Sleep Research Laboratory, University of Chicago, IL 60637, USA.
Sleep
|November 1, 1996
Summary
Adverse reactions to sedative/hypnotics like benzodiazepines are rare, with most mild and linked to therapeutic effects. Older adults over 55 experienced most reactions, with lorazepam showing a 0.05% incidence.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Patient Safety
Background:
- Sedative/hypnotics are widely prescribed for sleep and anxiety disorders.
- Understanding the real-world adverse event profile of these medications is crucial for safe clinical practice.
- Benzodiazepines are a common class of sedative/hypnotics with known side effect profiles.
Purpose of the Study:
- To systematically record and analyze adverse reactions associated with orally administered sedative/hypnotics.
- To determine the frequency and characteristics of adverse reactions to benzodiazepine sedative/hypnotics.
- To assess the severity, outcome, and probability of causation for reported adverse events.
Main Methods:
- Systematic recording of adverse reactions over a 3-year period in a teaching hospital.
- Review of reported cases by a multidisciplinary committee and pharmacist.
- Calculation of reaction frequency based on dispensed medication doses.
Main Results:
- Adverse reactions to benzodiazepine sedative/hypnotics were rare, with frequencies from 0.05% (lorazepam) to 0% (chlorazepate).
- The median reported adverse reaction frequency was 0.01% (1 in 10,000 doses).
- Most reactions were mild, considered extensions of therapeutic effects, and occurred in patients over 55.
Conclusions:
- Benzodiazepine sedative/hypnotics demonstrate a low frequency of reported adverse reactions in a clinical setting.
- Adverse events are typically mild and predictable extensions of pharmacological effects.
- Patient age is a significant factor, with older adults experiencing most reactions.